Showing results (51-60 of 655) with videos related to
Sort By:
Pageof 66
Journal of Managed Care Pharmacy : JMCP|November 18, 2011
Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitorsBenjamin Powers, Laurence Greene, Lisa M BalfeJournal of Managed Care Pharmacy : JMCP|January 13, 2012
Approaches to the management of agents used for the treatment of multiple sclerosis: consensus statements from a panel of U.S. managed care pharmacists and physiciansRoss M Miller, Laura E Happe, Kellie L Meyer, et al.Journal of Managed Care Pharmacy : JMCP|September 28, 2011
Determinants of medicare all-cause costs among elderly patients with renal cell carcinomaChristopher S Hollenbeak, Lucas E Nikkel, Eric W Schaefer, et al.Journal of Managed Care Pharmacy : JMCP|September 28, 2011
Transportation cost of anticoagulation clinic visits in an urban settingJamie M Hwang, Jennifer Clemente, Krishna P Sharma, et al.Journal of Managed Care Pharmacy : JMCP|June 5, 2012
Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an updateJasvinder A Singh, Davecia R CameronJournal of Managed Care Pharmacy : JMCP|November 15, 2011
IntroductionC Daniel Mullins, Robert J SanchezJournal of Managed Care Pharmacy : JMCP|November 15, 2011
Core management principles in rheumatoid arthritis to help guide managed care professionalsSandeep K AgarwalJournal of Managed Care Pharmacy : JMCP|November 15, 2011
Biologic agents in rheumatoid arthritis: an update for managed care professionalsSandeep K AgarwalJournal of Managed Care Pharmacy : JMCP|January 20, 2006
Impact of a clinical pharmacy consult service on guideline adherence and management of gabapentin for neuropathic painLisa M Winterbottom, Anna M Fong, Kristen L Benkstein, et al.Journal of Managed Care Pharmacy : JMCP|January 20, 2006
A pilot study of home treatment of deep vein thrombosis with subcutaneous once-daily enoxaparin plus warfarinBeverly Bishop, Andrew G Wilson, Douglas Post, et al.Pageof 66